Send us Feedback

Elan Corporation (ELN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ELN » Topics » Internet Website

This excerpt taken from the ELN 6-K filed Mar 31, 2008.
Internet Website
 
Information on the Company is available online via the Internet at our website, http://www.elan.com. Information on our website does not constitute part of this Annual Report. This Annual Report and our Form 20-F are available on our website.

Elan Corporation, plc 2007 Annual Report 155

Table of Contents

(This page intentionally left blank)
 

Table of Contents

(GRAPHIC)
 

 

Table of Contents

(GRAPHIC)
Elan Corporation, plc Treasury Building Lower Grand Canal Street Dublin 2, Ireland www.elan.com

 

This excerpt taken from the ELN 6-K filed Mar 30, 2007.
Internet Website
 
Information on the Company is available online via the Internet at our website, http://www.elan.com. Information on our website does not constitute part of this Annual Report. This Annual Report and our Form 20-F are available on our website.
 
154 Elan Corporation, plc 2006 Annual Report

Table of Contents

()
Elan people appearing in this Annual Report (alphabetical order) [Graphic Appears Here] Lisa McConlogue, PhD Research Fellow, Biology Mike McConnell Sr Director, Regulatory Affairs, Europe Richard McCourt Sr District Sales Manager, Hospital Products Donogh McGuire VP, Small Molecule Operations, EDT Connie Merron Assoc Director, Lead Discovery & Optimisation Terry Mix Sr District Sales Manager, Hospital Products Hassan Movahhed VP, Clinical Development Tara Nickerson, PhD Director, Corporate Strategy Declan O’Connor VP Finance, EDT Management Brid O’Flaherty Financial Controller, EDT Management Seamus O’Loan VP, Business Development, EDT Tim O’Shea VP, Hospital Specialty Business Group Anthony Pepio, PhD Director, Clinical Development Chris Petersen District Sales Manager, Hospital Products Bea Reed District Sales Manager, Hospital Products Tom Riordan VP, Legal, EDT Management Patrick Roberts VP & CISO, IT Governance & Control Quyen Schwing Research Associate, EDT Pharmaceutical Dev. Samnang Tep Research Associate, Pharmacology Edward Tefft Assoc Director, EDT Pharmaceutical Dev. Lori Taylor VP, Tysabri Management Randi Tillman, DMD Sr Director, Pricing & Reimbursement Marc Umans District Sales Manager, Hospital Products Robert Venteicher, PhD VP, Quality Assurance, R&D Donna Whiteford VP, Project Management Wagner Zago, PhD Scientist, Pharmacology Photographers: John Abbott, Arnold Bell, Mark Robert Halper, Juliana Thomas

 

Table of Contents

()
Elan Corporation, plc Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland. www.elan.com

 

This excerpt taken from the ELN 6-K filed Mar 31, 2006.
Internet Website
Information on the Company is available online via the Internet at our website, http://www.elan.com. Information on our website does not constitute part of this Annual Report. This Annual Report and our Form 20-F are available on our website.
Elan Corporation, plc 2005 Annual Report  173

Table of Contents

     ()
Elan people appearing in this Annual Report (alphabetical order) Nina Ashton VP, Intellectual Property Jennifer Johnston, PhD Principal Scientist, Biology Michael Babcock, PhD Post Doctoral Research Fellow Raj Kewalramani Sr Manager, Pharmaceutical Development Menghis Bairu, MD VP, Head of Global Medical Affairs Karen Kim EVP, Corp. Strat. & Alliances, Comm., Branding & Specialty Business Group Frédérique Bard, PhD VP, Biology Andrei Konradi, PhD Sr Director, Chemical Sheri Barrack, PhD VP, Biopharmaceutical Sciences Development Thomas Lecocq Sr Research Associate, Biology Joe Boudreau SVP, Health Care Systems Ivan Lieberburg, MD, PhD EVP, Chief Medical Paul Breen EVP, Elan Drug Technologies Officer Nancy Bryan SVP, Integrated Sales & Malcolm Lloyd-Smith VP, Global Services, Tysabri Regulatory Affairs James Callaway, PhD SVP, Alzheimer’s Kathleen Martorano EVP, Strategic Program Executive Human Resources Richard Chin, MD SVP, Head of Global Simon McGurk, PhD Sr Manager, Development Pharmaceutical Development Nigel Clerkin SVP, Finance and Group Elizabeth Messersmith, PhD Controller VP, Autoimmune Research Richard Collier EVP, General Counsel David Miller, PhD VP, Pharmacoeconomics Deborah Collins VP, Corporate Compliance Betsy O’Neill, PhD VP, Corporate Strategy Shane Cooke EVP, Chief Financial Officer Kyle Powell Sr Research Associate, Biology Liam Daniel EVP, Company Secretary Emer Reynolds VP, Investor Relations Chris Dax VP, Specialty Business Group-Prialt Donald Rudolph Associate Manager, DMPK Apurva Dixit Sr Sales Specialist-In-Field Trainer John-Michael Sauer, PhD Sr Director, Lead John Donahue SVP, Legal — Corporate Discovery & Optimization Lars Ekman, MD, PhD EVP, President, Global Kimberly Schafer Research Associate, EDT R&D, Head of Neurodegeneration Franchise Dale Schenk, PhD SVP, Chief Scientific Officer Roisín Foley Sr Director, Strategic Human Resources Peter Seubert, PhD VP, Neurodegeneration Research Gordon Francis VP, Global Clinical Development Raymond Townsend, PharmD Dora Games, PhD VP, In Vivo Pharmacology SVP, Pharmacoeconomics & Epidemiology
Jeannie Giacchino, MD, PhD VP, Program Chris Vandevert Scientist, Biology leader – Tysabri Nicki Vasquez, PhD Sr Director, Research Sabrina Gibson Research Associate, EDT Operations and Program Management Allison Hulme, PhD EVP, Autoimmune, Nancy Wehner, PhD Sr Director, Nonclinical Tysabri, Global Development Safety Evaluation Zhen Jin Sr Research Associate, Biology Ted Yednock, PhD SVP, Head of Kelly Johnson-Wood Principal Scientist, Biology Global Research Thank you to: Dr. Maurizio Miglietta Design by DeSola Group Inc. Photographers: John Abbot. Arnold Bell. Mark Robert Halper

Table of Contents

()
Elan Corporation, plc. Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland. www.elan.com

 

This excerpt taken from the ELN 6-K filed Apr 11, 2005.

Internet Website

Information on the Company is available online via the Internet at our website, http://www.elan.com. Information on our website does not constitute part of this Annual Report.

 

 

136

Elan Corporation, plc 2004 Annual Report

 


Design by DeSola Group Inc.

 

 

 

 

 



 

 

EXCERPTS ON THIS PAGE:

6-K
Mar 31, 2008
6-K
Mar 30, 2007
6-K
Mar 31, 2006
6-K
Apr 11, 2005

RELATED TOPICS for ELN:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki